Medication Fact Sheets
|
December 30, 2024

What Is Dextromethorphan? Comprehensive Guide to Cough Relief

Written By
Dr. Jaime Cloyd ND
Medically Reviewed by
Updated On
January 9, 2025

Have you ever wondered what's behind the effectiveness of your go-to cough medicine? When a persistent cough keeps you awake at night or disrupts your daily activities, reaching for an over-the-counter (OTC) remedy is often the first line of defense. 

Among these, dextromethorphan is one of the most widely used cough suppressants, an active ingredient in over 120 OTC cold medications. What makes it so effective, and what should you know about its use? This comprehensive guide delves into dextromethorphan's uses, safety profile, and potential risks.

[signup]

Understanding Dextromethorphan

Dextromethorphan (DXM) is a synthetic antitussive (cough suppressant) commonly found in over-the-counter (OTC) cough and cold medications. Approved by the Food and Drug Administration (FDA) in 1958, DXM has become a staple for managing cough symptoms associated with various respiratory conditions due to its effectiveness and lower risk profile compared to opioid-based suppressants.

Chemical Composition and Mechanism of Action

DXM is the d-isomer of levorphanol, an opioid closely related to codeine, which is known for its pain-relieving and euphoric effects. While chemically similar to opioids, DXM primarily functions as a cough suppressant by targeting sigma-opioid and NMDA receptors in the brain's cough center located in the medulla oblongata. By activating these receptors, DXM dampens the signals that trigger coughing.

This distinct mechanism sets DXM apart from traditional opioids like codeine or morphine. Unlike these opioids, DXM does not bind to mu-opioid receptors, which are responsible for pain-relieving and euphoric effects. Because of this, it carries a much lower risk of addiction and offers a safer alternative for managing cough symptoms. 

Over-the-Counter Medications

Dextromethorphan is an ingredient in most antitussive medications. It does not require a prescription and can be purchased over the counter alone or in combination with other drugs, such as analgesics (e.g., acetaminophen), antihistamines (e.g., chlorpheniramine), decongestants (e.g., pseudoephedrine), and expectorants (e.g., guaifenesin).  

Examples of commonly available brand-name products that contain dextromethorphan as an active ingredient include: 

Medical and Non-Medical Uses

Dextromethorphan is FDA-approved for the temporary relief of coughs caused by minor throat and bronchial irritation. It is often recommended as part of combination therapies to manage symptoms of the common cold, bronchitis, and other respiratory infections.

Beyond its traditional role, recent research has explored dextromethorphan's potential in treating neurological conditions as a neuroprotective agent. Studies have investigated its efficacy as an adjunct therapy for conditions such as: 

The effectiveness of dextromethorphan for these conditions is still under investigation and not FDA-approved. Always consult a healthcare professional before using medications for off-label purposes.

In 2010, the FDA approved the combination drug dextromethorphan/quinidine (sold under the brand name Nuedexta) for treating pseudobulbar affect (PBA), a condition characterized by episodes of uncontrollable laughing or crying. 

Most recently, in 2022, the FDA approved dextromethorphan/bupropion (sold under the brand name Auvelity) for treating major depressive disorder. 

Non-Medical Usage

While the abuse and addictive potential of DXM is generally lower than that of opioids, recreational misuse of DXM, often referred to as "robotripping," involves consuming large quantities of the medication to achieve euphoric, hallucinogenic, and dissociative effects. 

The therapeutic recommended adult dose of DXM for cough is 15-30 mg three to four times daily. To get high, people might take as much as 1,500 mg in a single dose. 

The behavioral effects of supra-therapeutic doses of DXM are dose-dependent: 

  • 100-200 mg: mild stimulation
  • 200-400 mg: euphoria and hallucinations
  • 300-1,500 mg: distorted visual perceptions, loss of motor coordination, and out-of-body sensations

Controversies surrounding DXM misuse include its easy accessibility and the perception of it being a "safe" drug due to its over-the-counter status. OTC Coricidin, Nyquil, and Robitussin formulations account for the majority of reported DXM misuse cases among people ages 12-25 years in the United States. 

This has led to calls for stricter regulations to control its sale, particularly to minors. Some jurisdictions have implemented age restrictions and placed DXM behind pharmacy counters to mitigate misuse. 

Potential Risks and Side Effects

When taken as prescribed by a doctor, DXM side effects are rare. High doses (greater than 4 mg/kg) are more likely to cause side effects, including:

  • A sensation of feeling drunk or high
  • Nausea and vomiting
  • Involuntary, rhythmic eye movements (nystagmus)
  • Dizziness

Side effects are more common when DXM is taken with other medications, particularly monoamine oxidase inhibitors (MAOIs), which are a class of drugs used to treat depression.

DXM overdose should be treated in an emergency room setting. While severe consequences are not common, immediate medical attention is necessary to manage symptoms, which may include: 

  • Slow, labored, and shallow breathing
  • Cyanosis (blue discoloration of the skin, lips, and nails)
  • Blurred vision
  • Constipation
  • Seizures
  • Drowsiness
  • Slow, unsteady walking
  • Hallucinations
  • High or low blood pressure
  • Muscle twitches
  • Nausea and vomiting
  • Rapid and irregular heartbeat
  • Raised body temperature
  • Loss of consciousness

Special Populations

Special considerations should be taken before using DXM in certain populations

  • Children: Caution should be taken when using DXM in young children. Liquid and capsule forms of DXM can be given to children ages 12 and older. The use of DXM capsules is not suitable for children younger than 12 years old. 
  • Pregnant Women: Limited data exist on the use of dextromethorphan during pregnancy. Pregnant women should consult their healthcare provider before using any OTC cough medication.
  • Elderly: Older adults may be more susceptible to the side effects of dextromethorphan, such as dizziness and drowsiness, which can increase the risk of falls and other accidents.

Guidelines for Safe Use

Dextromethorphan should be taken by mouth, following the instructions on the product label or as directed by your doctor. Dosage may vary based on individual health conditions. Always consult a healthcare provider for personalized dosage recommendations.

General dosage guidelines are as follows: 

Extended Release Liquid Suspension

  • Ages 12 and Older: 60 mg (10 mL) by mouth every 12 hours as needed. Don't exceed 120 mg (20 mL) in a 24-hour period. 
  • Ages 6-11: 30 mg (5 mL) every 12 hours as needed. Don't exceed 60 mg (10 mL) in a 24-hour period. 
  • Ages 4-5: 15 mg (2.5 mL) every 12 hours as needed. Don't exceed 30 mg (5 mL) in a 24-hour period.
  • Not suitable for children under 4 years. 

Immediate Release Liquid-Filled Capsules

  • Ages 12 and Older: 30 mg every 6-8 hours as needed. Don't take more than 120 mg in a 24-hour period. 
  • Not suitable for children under 12 years. 

Dextromethorphan is not recommended in certain situations. Tell your doctor before taking DXM if you have any of the following conditions:

  • Cough that produces a lot of mucus
  • Chronic cough related to asthma, smoking, or chronic obstructive pulmonary disease (COPD)
  • Pregnant or trying to get pregnant
  • Breastfeeding
  • Liver disease
  • History of an allergic reaction to DXM or a similar drug
  • You have taken an MAOI within the past two weeks

Frequently Asked Questions

Can I Take Dextromethorphan With Other Medications?

Dextromethorphan can be taken with other medications, such as guaifenesin and acetaminophen, but caution is required due to potential drug interactions. You should always consult a healthcare provider or pharmacist before combining dextromethorphan with other medications to prevent adverse interactions.

Is Dextromethorphan Safe for Children Under Six?

The safety and efficacy of dextromethorphan in children under six years old have not been well-established. Therefore, it is generally not recommended for this age group unless specifically directed by a healthcare professional.

What Should I Do In Case of an Overdose?

If you think you've taken too much DXM, immediately call 911 or a poison control center, such as America's Poison Centers, for assistance.

[signup]

Key Takeaways

  • Dextromethorphan is one of the most widely available over-the-counter cough suppressants used to manage cough symptoms associated with colds and other respiratory conditions.
  • Compared to other opioid antitussives, it has a favorable safety profile and is easily accessible, making it a go-to treatment option. 
  • Like all medications, dextromethorphan comes with potential risks and side effects. Users should be aware of these to ensure safe and responsible use. Always consult a healthcare provider before using this medication to understand its associated benefits and risks.
  • Stay informed about over-the-counter medication safety and share this guide to help others make educated decisions about their cough relief strategies.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!
  1. AGS AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults Guideline Summary. (2023, May 4). Guideline Central. https://www.guidelinecentral.com/guideline/340784/
  2. Albers, G. W., Sáenz, R. E., Moses, J. A., et al. (1991). Safety and tolerance of oral dextromethorphan in patients at risk for brain ischemia. Stroke, 22(8), 1075–1077. https://doi.org/10.1161/01.str.22.8.1075
  3. Bronchitis. (2022, September 8). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/3993-bronchitis
  4. Carlsson, K. C., Hoem, N. O., Moberg, E. R., et al. (2004). Analgesic effect of dextromethorphan in neuropathic pain. Acta Anaesthesiologica Scandinavica, 48(3), 328–336. https://doi.org/10.1111/j.0001-5172.2004.0325.x
  5. Chez, M., Kile, S., Lepage, C., et al. (2018). A Randomized, Placebo-Controlled, Blinded, Crossover, Pilot Study of the Effects of Dextromethorphan/Quinidine for the Treatment of Neurobehavioral Symptoms in Adults with Autism. Journal of Autism and Developmental Disorders, 50(5), 1532–1538. https://doi.org/10.1007/s10803-018-3703-x
  6. Chyka, P. A., Erdman, A. R., Manoguerra, A. S., et al. (2007). Dextromethorphan poisoning: An evidence-based consensus guideline for out-of-hospital management. Clinical Toxicology, 45(6), 662–677. https://doi.org/10.1080/15563650701606443
  7. Common cold. (2019). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/12342-common-cold
  8. Dextromethorphan. ScienceDirect. https://www.sciencedirect.com/topics/neuroscience/dextromethorphan
  9. dextromethorphan (OTC). Medscape. https://reference.medscape.com/drug/balminil-dm-benylin-dm-dextromethorphan-343401#0
  10. DEXTROMETHORPHAN HBR 15 MG capsule, liquid filled. (2022). DailyMed; National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2175017-6a0d-0155-e053-2995a90a65d6
  11. Dextromethorphan overdose. Mount Sinai Health System. https://www.mountsinai.org/health-library/poison/dextromethorphan-overdose
  12. Dextromethorphan Solution. Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/20631-dextromethorphan-solution
  13. Fisher, R. S., Cysyk, B. J., Lesser, R. P., et al. (1990). Dextromethorphan for treatment of complex partial seizures. Neurology, 40(3 Pt 1), 547–549. https://doi.org/10.1212/wnl.40.3_part_1.547
  14. Liu, C.-T., Kao, L.-T., Shih, J.-H., et al. (2019). The effect of dextromethorphan use in Parkinson's disease: A 6-hydroxydopamine rat model and population-based study. European Journal of Pharmacology, 862, 172639. https://doi.org/10.1016/j.ejphar.2019.172639
  15. McCarthy, B., Bunn, H., Santalucia, M., et al. (2023). Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder. Clinical Psychopharmacology and Neuroscience, 21(4), 609–616. https://doi.org/10.9758/cpn.23.1081
  16. Middleton, J. (2022, October 24). Meet the newest antidepressant: dextromethorphan/buproprion (Auvelity). American Academy of Family Physicians. https://www.aafp.org/pubs/afp/afp-community-blog/entry/meet-the-newest-antidepressant-dextromethorphan_buproprion-Auvelity.html
  17. NUEDEXTA - HIGHLIGHTS OF PRESCRIBING INFORMATION. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021879s000lbl.pdf
  18. Oh, S., Agrawal, S., Sabir, S., et al. (2019, October 2). Dextromethorphan. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK538216/
  19. Pasternak, G. W., & Pan, Y.-X. (2013). Mu Opioids and Their Receptors: Evolution of a Concept. Pharmacological Reviews, 65(4), 1257–1317. https://doi.org/10.1124/pr.112.007138
  20. Preventing Dextromethorphan Abuse. (2024, December 2). Consumer Healthcare Products Association. https://www.chpa.org/about-consumer-healthcare/activities-initiatives/preventing-dextromethorphan-abuse
  21. Pseudobulbar affect. (2018, May 16). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/pseudobulbar-affect/symptoms-causes/syc-20353737
  22. Pu, B., Xue, Y., Wang, Q., et al. (2015). Dextromethorphan provides neuroprotection via anti-infammatory and anti-excitotoxicity effects in the cortex following traumatic brain injury. Molecular Medicine Reports, 12(3), 3704–3710. https://doi.org/10.3892/mmr.2015.3830
  23. Rosenbaum, C., & Boyer, E. W. (2023). Dextromethorphan misuse and poisoning: Clinical features and diagnosis. UpToDate. https://www.uptodate.com/contents/dextromethorphan-misuse-and-poisoning-clinical-features-and-diagnosis
  24. Smith Haghighi, A. (2022, April 28). What To Know About Tripping on DXM. Medical News Today. https://www.medicalnewstoday.com/articles/dxm-trip
  25. Stanciu, C. N., Penders, T. M., & Rouse, E. M. (2016). Recreational use of dextromethorphan, “Robotripping”-A brief review. The American Journal on Addictions, 25(5), 374–377. https://doi.org/10.1111/ajad.12389
  26. Tsai, A., & Hannemann, K. (2021, July 15). What Is Dextromethorphan (Delsym)? GoodRx. https://www.goodrx.com/dextromethorphan/what-is#dosage
  27. WHAT IS DXM? (2020). Department of Justice/Drug Enforcement Administration. https://www.dea.gov/sites/default/files/2020-06/DXM-2020.pdf
  28. Wilson, E. (2024, December 10). How DXM and Guaifenesin Work Together for Cough and Congestion Relief. Rupa Health. https://www.rupahealth.com/post/how-dxm-and-guaifenesin-work-together-for-cough-and-congestion-relief
Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.